Combination biologic therapy for the treatment of severe palmoplantar pustulosis

JAAD Case Reports

Volumn 3, Issue 3, 2017, Pages 240-242

  Torre, Kristin M ^a   Payette, Michael J ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

biologics; combination therapy; palmoplantar inflammation; psoriasis; pustulosis

Indexed keywords

ADALIMUMAB; BOTULINUM TOXIN A; CYCLOSPORIN; METHOTREXATE; MYCOPHENOLIC ACID; PREDNISONE; STEROID; USTEKINUMAB;

ADULT; ARTICLE; BIOLOGICAL THERAPY; CASE REPORT; CLINICAL FEATURE; DACTYLITIS; DERMATITIS; DIFFERENTIAL DIAGNOSIS; DISEASE CLEARANCE; DISEASE SEVERITY; DRUG DOSE SEQUENCE; DRUG MEGADOSE; DRUG TREATMENT FAILURE; ERYTHEMA; HALLUX; HUMAN; HYPERHIDROSIS; MALE; POMPHOLYX; PRIORITY JOURNAL; PUSTULAR PSORIASIS; PUSTULOSIS PALMOPLANTARIS; SKIN ALLERGY; TREATMENT PLANNING; TREATMENT RESPONSE; ULTRAVIOLET B RADIATION;

EID: 85019217242     PISSN: None     EISSN: 23525126     Source Type: Journal    
DOI: 10.1016/j.jdcr.2017.03.002     Document Type: Article

References (6)

1. 1 Nestle, F.O., Kaplan, D.H., Barker, J., Psoriasis. N Engl J Med 361 (2009), 496–509.
2. 2 Deng, Y., Chang, C., Lu, Q., The inflammatory response in psoriasis: a comprehensive review. Clin Rev Allergy Immunol 50 (2016), 377–389.
3. 3 Zaba, L.C., Cardinale, I., Gilleaudeau, P., et al. Amelioration of epidermal hyperplasia by TNF inhibition Is associated with reduced Th17 responses. J Exp Med 204 (2007), 3183–3194.
4. 4 Babalola, O., Lakdawala, N., Strober, B.E., Combined biologic therapy for the treatment of psoriasis and psoriatic arthritis: A case report. JAAD Case Rep 1 (2015), 3–4.
5. 5 Cheng, J., Feldman, S.R., The cost of biologics for psoriasis is increasing. Drugs Context 3 (2014), 212–266.
6. 6 D'Souza, L.S., Payette, M.J., Estimated cost efficacy of systemic treatments that are approved by the US Food and Drug Administration for the treatment of moderate to severe psoriasis. J Am Acad Dermatol 72 (2014), 589–598.